SCHEMBL7455589

SCHEMBL7455589

CCCc1c(CO[Si](C)(C)C(C)(C)C)ccc2[nH]c(CN)nc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7456245 0.89 — —
SCHEMBL7450159 0.73 KDM4E (0.34) —
SCHEMBL7464101 0.67 MPO (0.32) —
SCHEMBL5201596 0.65 MGAM (0.43) —
SCHEMBL8536561 0.64 NPC1 (0.32) —
SCHEMBL16880557 0.63 BACE1 (0.34) —
SCHEMBL20558194 0.63 BACE1 (0.38) —
SCHEMBL2873807 0.63 AAK1 (0.35) —
SCHEMBL5738714 0.63 CBFB (0.45) —
SCHEMBL21587953 0.63 BACE1 (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165557-A1 ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS NEUROGEN CORPORATION (US) 2002-01-02 — — EP disclosed
WO-2000059905-A1 ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS NEUROGEN CORPORATION (US) 2000-10-12 — — WO disclosed
Send feedback